 | • レポートコード：GIR-107A15069 • 出版社/出版日：GlobalInfoResearch / 2021年7月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、100ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医薬品 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料では、プレリキサフォルのグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。プレリキサフォルの種類別市場規模（24MG / 1.2ML、タイプII）、用途別市場規模（非ホジキンリンパ腫（NHL）患者、多発性骨髄腫（MM）患者）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・プレリキサフォルの市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：sanofi-aventis ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：24MG / 1.2ML、タイプII ・用途別分析2016年-2026年：非ホジキンリンパ腫（NHL）患者、多発性骨髄腫（MM）患者 ・プレリキサフォルの北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・プレリキサフォルのヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・プレリキサフォルのアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・プレリキサフォルの南米市場規模2016年-2026年：ブラジル、アルゼンチン ・プレリキサフォルの中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Plerixafor market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Plerixafor size is estimated to be USD xx million in 2026 from USD xx million in 2020, with a change XX% between 2020 and 2021. The global Plerixafor market size is expected to grow at a CAGR of xx% for the next five years.
Market segmentation
Plerixafor market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
24MG/1.2ML
Type II
Market segment by Application, can be divided into
Non-Hodgkin’s lymphoma (NHL) Patients
Multiple myeloma (MM) Patients
Market segment by players, this report covers
sanofi-aventis
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
1 Market Overview
1.1 Product Overview and Scope of Plerixafor
1.2 Classification of Plerixafor by Type
1.2.1 Overview: Global Plerixafor Market Size by Type: 2020 Versus 2021 Versus 2026
1.2.2 Global Plerixafor Revenue Market Share by Type in 2020
1.2.3 24MG/1.2ML
1.2.4 Type II
1.3 Global Plerixafor Market by Application
1.3.1 Overview: Global Plerixafor Market Size by Application: 2020 Versus 2021 Versus 2026
1.3.2 Non-Hodgkin’s lymphoma (NHL) Patients
1.3.3 Multiple myeloma (MM) Patients
1.4 Global Plerixafor Market Size & Forecast
1.5 Global Plerixafor Market Size and Forecast by Region
1.5.1 Global Plerixafor Market Size by Region: 2016 VS 2021 VS 2026
1.5.2 Global Plerixafor Market Size by Region, (2016-2021)
1.5.3 North America Plerixafor Market Size and Prospect (2016-2026)
1.5.4 Europe Plerixafor Market Size and Prospect (2016-2026)
1.5.5 Asia-Pacific Plerixafor Market Size and Prospect (2016-2026)
1.5.6 South America Plerixafor Market Size and Prospect (2016-2026)
1.5.7 Middle East and Africa Plerixafor Market Size and Prospect (2016-2026)
1.6 Market Drivers, Restraints and Trends
1.6.1 Plerixafor Market Drivers
1.6.2 Plerixafor Market Restraints
1.6.3 Plerixafor Trends Analysis
2 Company Profiles
2.1 sanofi-aventis
2.1.1 sanofi-aventis Details
2.1.2 sanofi-aventis Major Business
2.1.3 sanofi-aventis Plerixafor Product and Solutions
2.1.4 sanofi-aventis Plerixafor Revenue, Gross Margin and Market Share (2019-2021)
2.1.5 sanofi-aventis Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Plerixafor Revenue and Share by Players (2019-2021)
3.2 Market Concentration Rate
3.2.1 Top 3 Plerixafor Players Market Share
3.2.2 Top 10 Plerixafor Players Market Share
3.2.3 Market Competition Trend
3.3 Plerixafor Players Head Office, Products and Services Provided
3.4 Mergers & Acquisitions
3.5 New Entrants and Expansion Plans
4 Market Size Segment by Type
4.1 Global Plerixafor Revenue and Market Share by Type (2016-2021)
4.2 Global Plerixafor Market Forecast by Type (2021-2026)
5 Market Size Segment by Application
5.1 Global Plerixafor Revenue Market Share by Application (2016-2021)
5.2 Plerixafor Market Forecast by Application (2021-2026)
6 North America by Country, by Type, and by Application
6.1 North America Plerixafor Revenue by Type (2016-2026)
6.2 North America Plerixafor Revenue by Application (2016-2026)
6.3 North America Plerixafor Market Size by Country
6.3.1 North America Plerixafor Revenue by Country (2016-2026)
6.3.2 United States Plerixafor Market Size and Forecast (2016-2026)
6.3.3 Canada Plerixafor Market Size and Forecast (2016-2026)
6.3.4 Mexico Plerixafor Market Size and Forecast (2016-2026)
7 Europe by Country, by Type, and by Application
7.1 Europe Plerixafor Revenue by Type (2016-2026)
7.2 Europe Plerixafor Revenue by Application (2016-2026)
7.3 Europe Plerixafor Market Size by Country
7.3.1 Europe Plerixafor Revenue by Country (2016-2026)
7.3.2 Germany Plerixafor Market Size and Forecast (2016-2026)
7.3.3 France Plerixafor Market Size and Forecast (2016-2026)
7.3.4 United Kingdom Plerixafor Market Size and Forecast (2016-2026)
7.3.5 Russia Plerixafor Market Size and Forecast (2016-2026)
7.3.6 Italy Plerixafor Market Size and Forecast (2016-2026)
8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific Plerixafor Revenue by Type (2016-2026)
8.2 Asia-Pacific Plerixafor Revenue by Application (2016-2026)
8.3 Asia-Pacific Plerixafor Market Size by Region
8.3.1 Asia-Pacific Plerixafor Revenue by Region (2016-2026)
8.3.2 China Plerixafor Market Size and Forecast (2016-2026)
8.3.3 Japan Plerixafor Market Size and Forecast (2016-2026)
8.3.4 South Korea Plerixafor Market Size and Forecast (2016-2026)
8.3.5 India Plerixafor Market Size and Forecast (2016-2026)
8.3.6 Southeast Asia Plerixafor Market Size and Forecast (2016-2026)
8.3.7 Australia Plerixafor Market Size and Forecast (2016-2026)
9 South America by Country, by Type, and by Application
9.1 South America Plerixafor Revenue by Type (2016-2026)
9.2 South America Plerixafor Revenue by Application (2016-2026)
9.3 South America Plerixafor Market Size by Country
9.3.1 South America Plerixafor Revenue by Country (2016-2026)
9.3.2 Brazil Plerixafor Market Size and Forecast (2016-2026)
9.3.3 Argentina Plerixafor Market Size and Forecast (2016-2026)
10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa Plerixafor Revenue by Type (2016-2026)
10.2 Middle East & Africa Plerixafor Revenue by Application (2016-2026)
10.3 Middle East & Africa Plerixafor Market Size by Country
10.3.1 Middle East & Africa Plerixafor Revenue by Country (2016-2026)
10.3.2 Turkey Plerixafor Market Size and Forecast (2016-2026)
10.3.3 Saudi Arabia Plerixafor Market Size and Forecast (2016-2026)
10.3.4 UAE Plerixafor Market Size and Forecast (2016-2026)
11 Research Findings and Conclusion
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
Table 1. Global Plerixafor Revenue by Type, (USD Million), 2020 VS 2021 VS 2026
Table 2. Global Plerixafor Revenue by Application, (USD Million), 2020 VS 2021 VS 2026
Table 3. Global Market Plerixafor Revenue (Million USD) Comparison by Region (2016 VS 2021 VS 2026)
Table 4. Global Plerixafor Revenue (USD Million) by Region (2016-2021)
Table 5. Global Plerixafor Revenue Market Share by Region (2021-2026)
Table 6. sanofi-aventis Corporate Information, Head Office, and Major Competitors
Table 7. sanofi-aventis Major Business
Table 8. sanofi-aventis Plerixafor Product and Solutions
Table 9. sanofi-aventis Plerixafor Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 10. Global Plerixafor Revenue (USD Million) by Players (2019-2021)
Table 11. Global Plerixafor Revenue Share by Players (2019-2021)
Table 12. Breakdown of Plerixafor by Company Type (Tier 1, Tier 2 and Tier 3)
Table 13. Plerixafor Players Head Office, Products and Services Provided
Table 14. Plerixafor Mergers & Acquisitions in the Past Five Years
Table 15. Plerixafor New Entrants and Expansion Plans
Table 16. Global Plerixafor Revenue (USD Million) by Type (2016-2021)
Table 17. Global Plerixafor Revenue Share by Type (2016-2021)
Table 18. Global Plerixafor Revenue Forecast by Type (2021-2026)
Table 19. Global Plerixafor Revenue by Application (2016-2021)
Table 20. Global Plerixafor Revenue Forecast by Application (2021-2026)
Table 21. North America Plerixafor Revenue by Type (2016-2021) & (USD Million)
Table 22. North America Plerixafor Revenue by Type (2021-2026) & (USD Million)
Table 23. North America Plerixafor Revenue by Application (2016-2021) & (USD Million)
Table 24. North America Plerixafor Revenue by Application (2021-2026) & (USD Million)
Table 25. North America Plerixafor Revenue by Country (2016-2021) & (USD Million)
Table 26. North America Plerixafor Revenue by Country (2021-2026) & (USD Million)
Table 27. Europe Plerixafor Revenue by Type (2016-2021) & (USD Million)
Table 28. Europe Plerixafor Revenue by Type (2021-2026) & (USD Million)
Table 29. Europe Plerixafor Revenue by Application (2016-2021) & (USD Million)
Table 30. Europe Plerixafor Revenue by Application (2021-2026) & (USD Million)
Table 31. Europe Plerixafor Revenue by Country (2016-2021) & (USD Million)
Table 32. Europe Plerixafor Revenue by Country (2021-2026) & (USD Million)
Table 33. Asia-Pacific Plerixafor Revenue by Type (2016-2021) & (USD Million)
Table 34. Asia-Pacific Plerixafor Revenue by Type (2021-2026) & (USD Million)
Table 35. Asia-Pacific Plerixafor Revenue by Application (2016-2021) & (USD Million)
Table 36. Asia-Pacific Plerixafor Revenue by Application (2021-2026) & (USD Million)
Table 37. Asia-Pacific Plerixafor Revenue by Region (2016-2021) & (USD Million)
Table 38. Asia-Pacific Plerixafor Revenue by Region (2021-2026) & (USD Million)
Table 39. South America Plerixafor Revenue by Type (2016-2021) & (USD Million)
Table 40. South America Plerixafor Revenue by Type (2021-2026) & (USD Million)
Table 41. South America Plerixafor Revenue by Application (2016-2021) & (USD Million)
Table 42. South America Plerixafor Revenue by Application (2021-2026) & (USD Million)
Table 43. South America Plerixafor Revenue by Country (2016-2021) & (USD Million)
Table 44. South America Plerixafor Revenue by Country (2021-2026) & (USD Million)
Table 45. Middle East & Africa Plerixafor Revenue by Type (2016-2021) & (USD Million)
Table 46. Middle East & Africa Plerixafor Revenue by Type (2021-2026) & (USD Million)
Table 47. Middle East & Africa Plerixafor Revenue by Application (2016-2021) & (USD Million)
Table 48. Middle East & Africa Plerixafor Revenue by Application (2021-2026) & (USD Million)
Table 49. Middle East & Africa Plerixafor Revenue by Country (2016-2021) & (USD Million)
Table 50. Middle East & Africa Plerixafor Revenue by Country (2021-2026) & (USD Million)
List of Figures
Figure 1. Plerixafor Picture
Figure 2. Global Plerixafor Revenue Market Share by Type in 2020
Figure 3. 24MG/1.2ML
Figure 4. Type II
Figure 5. Plerixafor Revenue Market Share by Application in 2020
Figure 6. Non-Hodgkin's lymphoma (NHL) Patients Picture
Figure 7. Multiple myeloma (MM) Patients Picture
Figure 8. Global Plerixafor Revenue, (USD Million): 2020 VS 2021 VS 2026
Figure 9. Global Plerixafor Revenue and Forecast (2016-2026) & (USD Million)
Figure 10. Global Plerixafor Revenue Market Share by Region (2016-2026)
Figure 11. Global Plerixafor Revenue Market Share by Region in 2020
Figure 12. North America Plerixafor Revenue (USD Million) and Growth Rate (2016-2026)
Figure 13. Europe Plerixafor Revenue (USD Million) and Growth Rate (2016-2026)
Figure 14. Asia-Pacific Plerixafor Revenue (USD Million) and Growth Rate (2016-2026)
Figure 15. South America Plerixafor Revenue (USD Million) and Growth Rate (2016-2026)
Figure 16. Middle East and Africa Plerixafor Revenue (USD Million) and Growth Rate (2016-2026)
Figure 17. Plerixafor Market Drivers
Figure 18. Plerixafor Market Restraints
Figure 19. Plerixafor Market Trends
Figure 20. sanofi-aventis Recent Developments and Future Plans
Figure 21. Global Plerixafor Revenue Share by Players in 2020
Figure 22. Plerixafor Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
Figure 23. Global Top 3 Players Plerixafor Revenue Market Share in 2020
Figure 24. Global Top 10 Players Plerixafor Revenue Market Share in 2020
Figure 25. Key Players Market Share Trend (Top 3 Market Share: 2019 VS 2020 VS 2021)
Figure 26. Global Plerixafor Revenue Share by Type in 2020
Figure 27. Global Plerixafor Market Share Forecast by Type (2021-2026)
Figure 28. Global Plerixafor Revenue Share by Application in 2020
Figure 29. Global Plerixafor Market Share Forecast by Application (2021-2026)
Figure 30. North America Plerixafor Sales Market Share by Type (2016-2026)
Figure 31. North America Plerixafor Sales Market Share by Application (2016-2026)
Figure 32. North America Plerixafor Revenue Market Share by Country (2016-2026)
Figure 33. United States Plerixafor Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 34. Canada Plerixafor Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 35. Mexico Plerixafor Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 36. Europe Plerixafor Sales Market Share by Type (2016-2026)
Figure 37. Europe Plerixafor Sales Market Share by Application (2016-2026)
Figure 38. Europe Plerixafor Revenue Market Share by Country (2016-2026)
Figure 39. Germany Plerixafor Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 40. France Plerixafor Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 41. United Kingdom Plerixafor Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 42. Russia Plerixafor Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 43. Italy Plerixafor Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 44. Asia-Pacific Plerixafor Sales Market Share by Type (2016-2026)
Figure 45. Asia-Pacific Plerixafor Sales Market Share by Application (2016-2026)
Figure 46. Asia-Pacific Plerixafor Revenue Market Share by Region (2016-2026)
Figure 47. China Plerixafor Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 48. Japan Plerixafor Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 49. South Korea Plerixafor Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 50. India Plerixafor Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 51. Southeast Asia Plerixafor Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 52. Australia Plerixafor Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 53. South America Plerixafor Sales Market Share by Type (2016-2026)
Figure 54. South America Plerixafor Sales Market Share by Application (2016-2026)
Figure 55. South America Plerixafor Revenue Market Share by Country (2016-2026)
Figure 56. Brazil Plerixafor Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 57. Argentina Plerixafor Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 58. Middle East and Africa Plerixafor Sales Market Share by Type (2016-2026)
Figure 59. Middle East and Africa Plerixafor Sales Market Share by Application (2016-2026)
Figure 60. Middle East and Africa Plerixafor Revenue Market Share by Country (2016-2026)
Figure 61. Turkey Plerixafor Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 62. Saudi Arabia Plerixafor Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 63. UAE Plerixafor Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 64. Methodology
Figure 65. Research Process and Data Source
世界のプレリキサフォー市場予測（～2024年） Plerixafor (INN and USAN, trade name Mozobil) is an immunostimulant used to mobilize hematopoietic stem cells in cancer patients into the bloodstream. Scope of the Report: The global Plerixafor market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, gro…- 世界のホジキンリンパ腫治療薬市場 2021：企業別、地域別、種類・用途別 The Hodgkin's Lymphoma Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regula…
- 世界の多発性骨髄腫用モノクローナル抗体市場 2021：企業別、地域別、種類・用途別 The Monoclonal Antibody for Multiple Myeloma market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimizati…
- 世界の多発性骨髄腫用従来型化学療法薬市場 2021：企業別、地域別、種類・用途別 The Traditional Chemotherapy Drugs for Multiple Myeloma market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain…
- 世界のCXCR4拮抗薬市場 2021：企業別、地域別、種類・用途別 The CXCR4 Antagonists market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, …